ESSA Pharma Inc (EPIX)
5.86
-0.39
(-6.24%)
USD |
NASDAQ |
May 17, 16:00
5.86
0.00 (0.00%)
After-Hours: 20:00
ESSA Pharma Cash from Investing (Quarterly): 62.51M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 62.51M |
| December 31, 2023 | 8.232M |
| September 30, 2023 | -0.2646M |
| June 30, 2023 | -0.8911M |
| March 31, 2023 | -0.8772M |
| December 31, 2022 | -1.494M |
| September 30, 2022 | -3.348M |
| June 30, 2022 | -12.08M |
| March 31, 2022 | -26.63M |
| December 31, 2021 | -11.00M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.0113M |
| March 31, 2021 | -35.00M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -21.74M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.2014M |
| March 31, 2019 |
| Date | Value |
|---|---|
| December 31, 2018 | |
| September 30, 2018 | -0.2014M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -0.008M |
| December 31, 2015 | -0.002M |
| September 30, 2015 | -0.0598M |
| June 30, 2015 | -0.0491M |
| March 31, 2015 | -0.0097M |
| December 31, 2014 | -0.0555M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-35.00M
Minimum
Mar 2021
62.51M
Maximum
Mar 2024
-2.231M
Average
-0.2646M
Median
Sep 2023
Cash from Investing (Quarterly) Benchmarks
| Acasti Pharma Inc | -6.554M |
| Aurinia Pharmaceuticals Inc | -6.257M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -0.057M |
| Xenon Pharmaceuticals Inc | -46.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.818M |
| Cash from Financing (Quarterly) | 0.6436M |
| Free Cash Flow | -23.00M |
| Free Cash Flow Per Share (Quarterly) | -0.1541 |
| Free Cash Flow Yield | -9.14% |